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Hantaviruses are zoonotic agents transmitted from small mammals, mainly rodents, to humans, where 
they provoke diseases such as Hemorrhagic fever with Renal Syndrome (HFRS) and its mild form, 
Nephropathia Epidemica (NE), or Hantavirus Cardio-Pulmonary Syndrome (HCPS). Hantaviruses are 
spread worldwide and monitoring animal reservoirs is of primary importance to control the zoonotic 
risk. Here, we describe the development of a pan-viral resequencing microarray (PathogenID v3.0) 
able to explore the genetic diversity of rodent-borne hantaviruses endemic in Europe. Among about 
800 sequences tiled on the microarray, 52 correspond to a tight molecular sieve of hantavirus probes 
covering a large genetic landscape. RNAs from infected animal tissues or from laboratory strains have 
been reverse transcribed, amplified, then hybridized to the microarray. A classical BLASTN analysis 
applied to the sequence delivered through the microarray allows to identify the hantavirus species 
up to the exact geographical variant present in the tested samples. Geographical variants of the most 
common European hantaviruses from France, Germany, Slovenia and Finland, such as Puumala virus, 
Dobrava virus and Tula virus, were genetically discriminated. Furthermore, we precisely characterized 
geographical variants still unknown when the chip was conceived, such as Seoul virus isolates, recently 
emerged in France and the United Kingdom.
Hantaviruses are enveloped tri-segmented negative-stranded RNA viruses belonging to the Hantaviridae fam-
ily, Bunyavirales order, according to the 2018 classification of the International Committee on Taxonomy of 
Viruses (ICTV)1. Hantaviruses are distributed worldwide, their animal reservoirs are rodents, insectivores or bats 
(orders Rodentia, Soricomorpha, Chiroptera). When rodent-borne orthohantaviruses are transmitted to humans 
through aerosolized excreta of infected rodent reservoirs, they can provoke Hemorrhagic Fever with Renal 
Syndrome (HFRS), its mild form Nephropathia Epidemica (NE), or Hantavirus Cardio-Pulmonary Syndrome 
(HCPS), mainly depending on the virus species and its genotype/strain. In Europe, cases of HFRS associated 
with Dobrava-Belgrade orthohantavirus (DOBV) and Seoul orthohantavirus (SEOV), and cases of NE associated 
with Puumala orthohantavirus (PUUV), are continuously reported in endemic areas such as the Balkans, the 
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Fennoscandia region, Germany, Belgium, The Netherlands, France, and more recently, United Kingdom2–8. Tools 
to investigate the genetic diversity of hantaviruses in their animal reservoirs along their geographical distribu-
tion are particularly needed to better understand the epidemiology and predict hantavirus disease outbreaks in 
humans, and to set up appropriate public health measures9–14.
The recent development of molecular methods without an a priori hypothesis has brought a critical benefit 
in the field of diagnosis and research on infectious diseases. They can permit to obtain the sequence of a path-
ogen present in a biological sample, in absence of specific probes required for classic PCR or hybridization15–23. 
Among them, Next Generation Sequencing (NGS) have become widely used for identification and whole genome 
sequencing of novel animal or zoonotic pathogens and metagenome analysis22,23. These techniques are more 
accessible in terms of equipment and cost, but still require a complex downstream bioinformatics analysis which 
may represent a cumbersome step demanding a specific expertise. On the other hand, resequencing microarray 
do not demand a sophisticated analysis for interpretation. Indeed, the sequence obtained following hybridization 
of the amplified genetic material on the chip is used without any intermediate step for both BLASTN enquiry 
and phylogenetic analysis. Although the random amplification does not allow to specifically concentrate the viral 
material present in the specimen compared to classic or multiplex PCR assays, the following hybridization step on 
the resequencing microarray further improves the sensitivity and the specificity of the assay. In addition, the assay 
has the advantage of tolerating critical divergence levels, up to 20%, permitting a precise characterization from a 
short stretch of about 20 detected nt20, that can hardly be achieved when few reads are obtained following NGS 
assays. Resequencing microarray has been broadly used over the last ten years, for the detection and identification 
of emerging agents, such as monkeypox virus17,18, pandemic influenza viruses19, hemorrhagic fever viruses20, 
rhabdoviruses21. Several steps of the assay can be performed in the field (mobile laboratory) including sample 
preparation, random amplification by Phy29 (stable at room temperature) up to hybridization on the microarray. 
A specific equipment (fluidic station/scanner) is only required for the post-hybridization analysis and scanning.
PathogenID is a collaborative effort of teams of Institut Pasteur that combined expertise to develop 3 genera-
tions of resequencing microarrays for the detection of different emerging pathogens, bacteria and viruses, during 
public health urgencies and for research studies. The 1st and 2nd generations of the microarray contained only a 
limited number of viral sequences, 46 (PathogenID v1.0) and 126 (PathogenID v2.0), respectively. In particular, 
only sequences of six prototype orthohantaviruses, mainly associated with human diseases, were included: PUUV, 
DOBV, SEOV, Hantaan orthohantavirus (HTNV), Sin Nombre orthohantavirus (SNV), Andes orthohantavirus 
(ANDV)17,20. The targeted sequence corresponded to part of the large (L) segment coding for the RNA-dependent 
RNA-polymerase (RdRp), reputed to be the most conserved region of the genome24. While PathogenID v2.0 has 
been validated for detection of DOBV, SEOV, HTNV, ANDV and SNV in infected Vero E6 cells, it was not for 
PUUV, yet the most commonly circulating orthohantavirus in Europe20.
Therefore, the 3rd generation resequencing microarray (PathogenID v3.0), employed in the present coop-
erative study at the European scale has been specialized for virus detection and contains more than 800 viral 
sequences. This pan-viral resequencing microarray covers many viral pathogens critical for both animal and pub-
lic health and in particular most of the known circulating species and variants of zoonotic viruses. Among those 
sequences, 52 were strategically chosen to cover the diversity of hantaviruses, in particular the most frequent 
rodent-borne species that are the only one reported today to have a zoonotic potential. The small (S) segment of 
the genome encoding the nucleocapsid (N) protein was chosen as target to design the probes since there are more 
efficient to discriminate variants within a species; in addition more reference sequences were present in GenBank 
at the moment of the pan-viral chip conception.
The present manuscript illustrates the use of the PathogenID v3.0 resequencing microarray to map the genetic 
diversity of several endemic hantaviruses mainly associated with human disease in Europe, such as PUUV, 
DOBV, including genotypes Dobrava and Saarema25, TULV, SEOV, Topografov hantavirus (TOPV) according to 
their geographical distribution.
Methods
Design of PathogenID v3.0 pan-viral resequencing microarray. The objective for the conception of 
the 3rd generation resequencing microarray (PathogenID v3.0) was to reach the widest coverage in virus diversity 
of both medical and veterinarian interest. Due to the technical limits of the microarray, we selected the minimum 
number of probes for each viral species/variant, in order to include the highest number of sequences. For each 
viral family, the included probes were chosen taking into account the reference sequences published in GenBank 
and our experience from the earlier generations of the microarray (PathogenID v1.0 and PathogenID v2.0)17–21.
PathogenID v3.0 contains 838 sequences including virus prototypes and their variants belonging to different 
families (complete list available upon request to the authors). Regarding hantaviruses, 52 N protein encoding S 
segment partial sequences were included (Table 1; Supplement 1), according to the known ICTV taxonomy in 
force when we designed the chip (e.g. choice of the probe sequences). The length of the tiled sequences was: i) 
425 nucleotides (nt) for those available in GenBank, with the exception of seq234 (251 nt); ii) 303 nt for those 
sequenced in the laboratory during previous analyses and not published at the moment of the study (Table 1; 
Supplement 1).
Upon sequence selection, PathogenID v3.0 was manufactured by Affymetrix (Santa Clara, California) accord-
ing to their high density resequencing approach, based on the use of stepwise overlapping 25 nt long probes, the 
first covering position 1–25 of the tiled sequence, the second position 2–26, etc.: each probe comprises a set of 
4 different alleles differing in the central 13th position (e.g. A, C, G or T)16,17. A total of 2.5 millions of 25 mer 
oligonucleotides were tiled on the microarray PathogenID v3.0.
Hantavirus plasmids. Synthetic plasmids containing the S segment of PUUV, the most endemic hantavirus 
in Europe (strain Sotkamo 2009), HTNV (strain 76/118), TULV (strain Moravia) were used in a preliminary assay 
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Family Hantaviridae  
(Species)
Isolate/Variant/strain 
Description*
GenBank 
Accession number
Sequence size (N segment 
size: nt-nt position)§
Position 
chip#
Puumala orthohantavirus
CG14444 AJ277075 425 (1837: 395–819) 222
CG 13891 U22423 425 (1847: 395–819) 223
Bavaria CG9/04 AY954722 425 (1722: 392–816) 224
Sotkamo NC 005224 X61035 425 (1830: 395–819) 225
Puu/Kazan_ Z84204 425 (1826: 395–819) 226
Umea/hu AY526219 425 (1829: 395–819) 227
PUU/Ernstbrunn/Cg641/1995 AJ888752 425 (1852: 395–819) 228
Berkel L36943 425 (1068: 224–648) 229
Couvin/59Cg/97 AJ277034 425 (1839: 395–819) 230
Pallasjarvi/63Cg/98 AJ314597 425 (1827: 395–819) 231
Munga/Mg16/05 GQ339487 425 (1854: 395–819) 232
PUU/Mignovillard/CgY02/2005 AM695638 425 (1851: 395–819) 233
France/Perpignan1999 AY101391 251 (251: 1–251)° 234
Fusong 900–06 EF488806 425 (1302: 353–777) 235
CH-214 Franche Comté KT247596^ 425 (1302: 353–777) 236
AR-21 Charleville Meziéres unpub^ 425 (1775: 364–786) 237
167-2 Charleville Meziéres unpub^ 303 (1302: 352–654) 238
167-4 Charleville Meziéres unpub^ 303 (1302: 352–654) 239
178-2 Charleville Meziéres unpub^ 303 (1302: 352–654) 240
180-78 Charleville Meziéres unpub^ 303 (1775: 362–664) 241
RU-11 Ruminy Troyes KY364996^ 303 (1785: 362–664) 242
OR-52 Orleans KT247595^ 303 (1302: 352–654) 243
Sin Nombre orthohantavirus Convict Creek 107 L33683 425 (2083: 395–819) 244
Dobrava-Belgrade orthohantavirus
Dobrava-Belgrade L41916 425 (1670: 388–812) 245
Esl/81Aa/01 AY533120 425 (1697: 388–812) 246
Saaremaa orthohantavirus Saaremaa/Lolland/Aa1403/2000 AJ616854 425 (1673: 388–812) 247
Kenkeme orthohantavirus MSB148794 GQ306148 425 (1640: 403–827) 248
Hantaan orthohantavirus & unclassified 
hantaviruses
1980471 M14626 425 (1696: 389–813) 249
KY GU140098 425 (1699: 389–813) 250
Z10 EF533944 425 (1701: 389–813) 251
AA1719 AF427319 425 (1643: 366–790) 252
CGHu1 EU092218 425 (1681: 389–813) 253
Q32 AB027097 425 (1635: 353–777) 254
Seoul orthohantavirus Z37 AF187082 425 (1754: 395–819) 255
Hantaan orthohantavirus Nc167 AB027523 425 (1654: 354–778) 256
Seoul orthohantavirus L99 AF488708 425 (1290: 353–777) 257
Seoul orthohantavirus 80-39 NC005236 425 (1769: 395–819) 258
Asama orthohantavirus N10 EU929072 425 (1710: 371–795) 259
Nova mobatvirus MSB95703 FJ539168 425 (1839: 405–829) 260
Prospect Hill orthohantavirus PHV 1980485 M34011 425 (1675: 395–819) 261
Soochong virus (unclass.) SC-1 AY675349 425 (1695: 388–812) 262
Tula orthohantavirus
Sennickerode Sen05/204 EU439950 425 (1700: 395–819) 263
Tula/Kosice144/Ma/95 Y13979 425 (1833: 395–819) 264
Tula/Moravia/5293 Ma/94 Z48574 425 (1832: 395–819) 265
MG23/Omsk AF442621 425 (1758: 353–777) 266
Thottapalayam thottivirus Thottapalayam 1980493 AY526097 425 (1530: 450–874) 267
Andes orthohantavirus
Chile-9717869 AF291702 425 (1871: 395–819) 268
NK104619 EU241691 425 (927: 189–613) 269
Sin Nombre orthohantavirus NM R11 L37904 425 (2060: 395–819) 270
New York orthohantavirus RI-1 44755 U09488 425 (2078: 395–819) 271
Choclo virus orthohantavirus 169173 DQ285046 425 (1972: 395–819) 272
Laguna Negra orthohantavirus 510B 1980476 AF005727 425 (1904: 395–819) 273
Table 1. List of 52 hantavirus sequences fixed on the panviral chip PathogenID v3.0. All sequences are partially 
targeting the S segment encoding the hantavirus nucleocapsid (N) protein. Complementary information is 
found in Supplement 1. *Description of the isolate/strain as indicated in GenBank or according to laboratory 
nomenclature for experimentally obtained sequences. §Position according to the corresponding sequence 
available in GenBank. °Sequence corresponding to a different region of the S gene. #The number is referred to 
the position on the pan-viral chip PathogenID v3.0 (total number: 838 sequences). ^unpublished at the moment 
of the study.
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to evaluate the potential of the microarray for hantavirus detection, prior testing the field animal samples. PUUV 
plasmid was taken as reference and tested alone and in pool with the HNTV and TULV plasmids.
Laboratory strains. Laboratory prototype strains of PUUV, DOBV (genotypes Dobrava and Saaremaa) 
TULV and TOPV isolated on Vero E6 cells in BSL3 containment were provided by the virology participant labo-
ratory in Finland26–30 (Fig. 1).
Endemic hantaviruses from wild rodents captured in Europe. Hantavirus rodent reservoirs of the 
Bank vole (Myodes glareolus), Common vole (Microtus arvalis), Yellow-necked mouse (Apodemus flavicolis), 
Striped field mouse (Apodemus agrarius), and Norway rat (Rattus norvegicus) were previously captured in differ-
ent hantavirus endemic areas in Europe: France, Germany, Finland, Slovenia, and United Kingdom30–41. Figure 1 
illustrates the capture areas and rodent species as well as the Institutes participating to the study and providing 
positive animals.
Lung samples were kept at −80 °C in RNAlater (Ambion, Thermo Fisher Scientific, Waltham, USA) prior 
to RNA extraction (QiaAmp Viral RNA Kit, Qiagen, Hilden, Germany). Hantavirus positive RNAs, routinely 
confirmed by the reference laboratories by RT-PCR30–41, were employed for exploring their genetic diversity by 
resequencing microarray.
France. PUUV, the most frequent hantavirus circulating in France, was obtained from bank voles samples cap-
tured in France in 2011 in the Ardennes region31, SEOV (Lyon strain) from Norway rats39.
Finland for Fennoscandia region. Lung tissues originating from PUUV-positive bank voles captured in 
Konnevesi in 2008 were used30.
Germany. PUUV and TULV RNAs originating from lungs of animal reservoirs captured across Germany32–36 
were used.
Balkan region. PUUV, TULV, DOBV RNAs originating from lungs were obtained from rodents captured in 
Slovenia37,38.
Figure 1. Cooperative work for genetic characterization study of endemic hantaviruses in Europe. 
Hantaviruses from rodents: Bank vole (Myodes glareolus), Common vole (Microtus arvalis), Yellow-necked 
mouse (Apodemus flavicolis), Striped field mouse (Apodemus agrarius), and Norway rat (Rattus norvegicus) 
captured in different endemic areas in Europe were genetically characterized using a resequencing pan-viral 
chip during a cooperative work among European research institutes: France, Germany, Scandinavia, Balkans, 
United Kingdom. Laboratory viral strains were also obtained from one of the participant laboratory. The tested 
RNA included: (i) RNA extracted from tissues (e.g. lung) originating from infected wild rodents; (ii) RNA 
extracted from supernatants from inoculated cells (Vero E6).
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United Kingdom. SEOV (Cherwell strain) obtained from organs of domestic rats in United Kingdom (UK) was 
used40,41.
All experiments were performed in accordance with relevant guidelines and regulations. RNAs extracted from 
tissue sample from wild animals were received from various Hantavirus Reference Centers in Europe (Fig. 1) 
through the EU program EVA (European Virus Archive - n° 228292) which facilitates access to virus/tissue 
library under MTA (Material Transfer Agreement). All of them have been previously published in peer-reviewed 
literature. All handling procedures of captured rodents followed the regulations of each respective country. The 
species studied are not protected and all efforts were made to minimize animal suffering.
Genetic detection and phylogeographical characterization of hantaviruses by the pan-viral 
chip PathogenID v3.0. The experimental procedure for hantavirus typing includes the following steps, 
detailed in previous works19,20 (Supplement 2).
RNA extraction. RNA was extracted using the QIAamp Viral RNA Extraction kit (Qiagen) from both animal 
organ homogenates or cell supernatants. cDNA was synthetized by Superscript III system (Invitrogen, Thermo 
Fisher).
Random amplification. Genetic material, either plasmid DNA, or cDNA from animal organs or cell supernatants, 
was amplified by WGA (Whole Genome Amplification) and WTA (Whole Transcriptome Amplification) approaches, 
respectively, using φ29 polymerase-mediated random amplification (Qiagen), followed by a ligation step17.
Hybridization on the microarray and sequence detection. Amplified products were hybridized overnight at 45 °C 
on the microarray PathogenID v3.0 after fragmentation and labeling using GeneChip Resequencing Reagent Kit 
(Affymetrix). Chips were then subjected to washing, fluorescence detection and scanning using the Affymetrix 
equipment (Wash Control, Scan Control). Resequencing analysis was performed using the software GSEQ. 4.1 
(Affymetrix). For each of the 52 hantavirus sequences fixed on the chip (positions seq222 to seq273), an output 
sequence was obtained in a .txt format, with determined (A, G, T or C) or non-determined (N) positions (exam-
ple in Supplement 2). Significant sequences obtained were used for Call Rate calculation and BLASTN analysis.
PUUV sequence on the chip 
(position)
Sequence similarity to PUUV Sotkamo 
(nbr identical nt/total nbr nt) - (%) BLASTN identification
Call Rate 
(CR) (%)
seq222 344/422 − 81.5 yes: Sotkamo 23.9
seq223 335/422 − 79.4 no 23.7
seq224 346/425 − 81.4 no 18.9
seq225* 425/425* − 100* yes: Sotkamo 97.7
seq226 351/425 − 82.6 no 26.2
seq227 357/424 − 84.2 yes: Sotkamo 39.6
seq228 346/423 − 81.8 yes: Sotkamo + FIN variants 22.7
seq229 346/425 − 81.4 no 19.4
seq230 347/422 − 82.2 yes: Sotkamo 33.9
seq231 387/423 − 91.5 yes: Sotkamo 75.0
seq232 353/424 − 83.2 yes: Sotkamo + FIN variants 34.4
seq233 342/424 − 80.7 yes: Sotkamo + FIN variants + others° 19.7
seq234# # yes: Sotkamo 62.1
seq235 323/422 − 76.5 no 7.0
seq236 343/424 − 80.9 yes: Sotkamo + FIN variants + others° 19.9
seq237 348/423 − 82.3 yes: Sotkamo 35.2
seq238 244/299 − 81.6 no 24.7
seq239 247/299 − 82.6 yes: Sotkamo 34.4
seq240 249/299 − 83.3 yes: Sotkamo 38.3
seq241 242/299 − 80.9 no 26.9
seq242 245/299 − 81.9 yes: Sotkamo + FIN variants + others° 30.8
seq243 246/301 − 81.7 no 25.1
Table 2. Validation of the Pathogen ID v3.0 resequencing microarray using a nucleocapsid (N) protein 
encoding plasmid of the PUUV prototype strain Sotkamo. A plasmid containing the N protein encoding 
sequence of the PUUV Sotkamo strain was used to evaluate the range of detection of the Pathogen ID v3.0 
resequencing microarray. Sequence identity (%) was calculated by aligning the tested Sotkamo PUUV sequence 
against each PUUV sequence tiled on the array (seq222–seq243). Following hybridization of the Sotkamo 
plasmid on the chip, each significant output sequence was evaluated by its Call Rate (CR) value (% of the 
correctly determined nucleotides of the sequence following hybridization) and the result(s) of its analysis by 
BLASTN. Complementary information is given in Supplement 3 and Fig. 2. *Sotkamo sequence tiled on the 
chip. #different region of the S segment tiled on the chip. °others: PUUV variants other than Sotkamo and 
Finnish (FIN) variants.
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Call Rate calculation. Call Rate (CR) was calculated as the ratio (%) between the number of determined (‘called’) 
nucleotides (e.g. A, G, T, C) following hybridization and the total number of nucleotides for each tiled sequence 
(e.g. 425, 251 or 303 nt, for hantaviruses).
BLASTN analysis. For samples presenting a minimum stretch of informative sequence20, the entire raw 
sequence was submitted to BLASTN (Basic Local Alignment Search Tool Nucleotide) query [National Center for 
Biotechnology Information, National Institute of Health], to interrogate all the sequences present in GenBank. 
In case of positive BLASTN result, scores, identity (%), query coverage (%) and e-value were taken into account.
Phylogenetic analysis. Phylogenetic analysis was performed for PUUV (as representative of European 
orthohantavirus) by using (i) the reference sequences (S segment) available on GenBank, (ii) the sequences tiled 
on the chip, (iii) the sequences corresponding to the tested hantaviruses, when known.
Firstly, a phylogenetic tree was constructed with the complete coding part of reference sequences by 
the maximum-likehood method (ML) with PhyML v3.0, implemented in Seaview (v.4.6.1) under the most 
appropriate nucleotide substitution model as determined by SMS program (available online at http://www.
atgc-montpellier.fr/sms/)42. Branch supports were evaluated by approximate likelihood-ratio test (aLRT SH-Like). 
Then, short sequences of the chips and of tested hantaviruses were placed in this backbone tree using RAxML 
available online on the CIPRES portal at (http://www.phylo.org). Branch supports of these phylogenetic place-
ments were evaluated by the rapid bootstrap procedure with MRE-based Bootstopping criterion as highly recom-
mended on the online software version.
For each sample giving a positive result following hybridization, BLASTN analysis of the resulting sequence, 
was pointed out on the phylogenetic tree, and compared to the sequences having permitted the detection and 
genetic characterization.
Results
Initial validation of the 3rd generation pan-viral resequencing microarray for hantavirus detec-
tion and genetic characterization. The performance in hantavirus detection and genetic characterization 
of the resequencing chip Pathogen ID v3.0 was first evaluated using plasmids encoding prototype hantavirus 
sequences (PUUV, HTNV, TULV). The PUUV plasmid encompassing the N protein coding region (1831 nt) 
of the reference Sotkamo strain 2009 was hybridized to Pathogen ID v3.0 which includes 22 PUUV S segment 
sequences (seq222 to seq243) (Table 1; Supplement 1). For each of these sequences, Table 2 summarizes (i) the 
calculated sequence similarity (%) with the tested PUUV Sotkamo strain sequence; (ii) the percentage of correctly 
identified nucleotides (CR) following its hybridization to the chip and (iii) the result of the BLASTN analysis 
performed with the obtained raw sequences (Supplement 3).
It clearly appeared that the CR values were proportional to the sequence similarity between the tested sequence 
and the tiled ones (Table 2). From 100% (seq225, Sotkamo itself) to 91.5% (seq231) of identity, the CR was very 
Figure 2. Performance of the Pathogen ID v3.0 resequencing microarray to detect and identify hantavirus 
sequences. A plasmid encoding the nucleocapsid (N) protein of the PUUV prototype strain Sotkamo was used 
to evaluate the range of detection of the Pathogen ID v3.0 resequencing microarray. This figure compares the 
calculated sequence identity (%) between the tested sequence (PUUV Sotkamo) and each PUUV sequences 
tiled on the microarray with the respective Call Rate (CR, i.e. % of determined nucleotides) obtained after 
hybridization. Colours, values and arrows outline a window of sequence identity (%) for BLASTN results 
obtained from each output sequence following hybridization: from no detection/identification (blue), to general 
PUUV characterization (Sotkamo + others, orange) to precise and exclusive characterization (Sotkamo, red). 
Complementary information is described in Table 2 and Supplements 3–4.
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Tested virus 
(geographical origin)
Tiled sequence allowing detection 
(position on the chip)
BLASTN identification Score 
(total)
Call rate 
(%)nbr sequences
PUUV 87 (France)
222: PUUV CG14444 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 226 65.6
223: PUUV CG13891 1 Ardennes_2011_87 89.1 35.9
230: Couvin/59Cg/97 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 351 73.8
237: AR-21 Charlesville_Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 268 67.8
238: 167-2 Charlesville-Mezieres 6 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 108 52.7
239: 167-4 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 288 78.5
240: 178-2 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 268 77.4
241: 180-78 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 239 73.8
PUUV 153 (France)
222: PUUV CG14444 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 488 83.0
223: PUUV CG13891 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 141 52.3
229: Berkel_L36943 28 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 44.6 26.4
230: Couvin/59Cg/97 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 581 89.5
234: Perpignan 1999 1 Ardennes/Mg156/2011 150 64.3
237: AR-21 Charlesville_Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 547 87.5
238: 167-2 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 156 68.1
239: 167-4 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 392 88.9
240: 178-2 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 408 91.0
241: 180-78 Charlesville-Mezieres 3 Ardennes_2011_87; Ardennes/Mg75/2011; Ardennes/Mg156/2011 345 84.2
PUUV Mu557 
Gilserberg/10 
(Germany)
223: PUUV CG13891 27 Mu557Gilserberg/10 44.6 33.4
230: Couvin/59Cg/97 1 Mu557Gilserberg/10 121 34.2
233: Mignovillard/CgY02/2005 1 Mu557Gilserberg/10 153 35.4
234: Perpignan1999 2 PUUV/NL/Mg591/2008; Heidelberg/hu 80.6 54.2
236: CH-214_Franche_Comté 1 Mu557Gilserberg/10 57.2 28.7
237: AR-21_Charlesville_Mezieres 1 Mu557Gilserberg/10 73.4 32.4
238: 167-2Charleville_Mezieres 1 Mu557Gilserberg/10 57.2 41.2
239: 167-4Charleville_Mezieres 1 Mu557Gilserberg/10 57.2 38.0
240: 178-2Charleville_Mezieres 7 Mu557Gilserberg/10 53.6 40.9
241: 180-78Charleville_Mezieres 1 Mu557Gilserberg/10 90.9 41.6
242: RU-11Ruminy-Troies 2 Mu557Gilserberg/10; H290 Fulda/10 64.4 30.8
PUUV Mu2232 
Bramsche/09 
(Germany)
224: Bavaria CG9/04 34 Mu2232Bramsche/09 60.8 31.2
229: Berkel_L36943 6 KS10/3078; KS14/873; KS14/715 158 39.7
233: Mignovillard/CgY02/2005 2 KS10/3078; KS14/778 94.5 28.4
234: Perpignan 1999 2 Mu/07/1219; Mu362Osnabrueck/05 48.2 41.0
242: RU-11RuminyTroyes 11 Mu2232Bramsche/09 60.8 30.5
243: OR-52_Orleans 42 Mu2232Bramsche/09 44.6 30.1
PUUV Mu978 
Weissach/10 
(Germany)
222: CG14444 6 Mu978Weissach/10 129 42.4
224: Bavaria CG9/04 3 Mu978Weissach/10 172 48.6
234: Perpignan1999 1 Heidelberg/hu 132 59.5
240: 178-2Charleville-Mezieres 6 Mu978Weissach/10 89.7 45.5
241: 180-78Charleville-Mezieres 6 Mu978Weissach/10 87.8 40.1
242: RU-Ruminy-Troyes 6 Mu978Weissach/10 75.2 39.4
PUUV laboratory 
strain Sotkamo
222: CG14444 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid protein 51.8 23.9
225: Sotkamo_NC_005224 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid protein 673 96.5
227: Umea 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid protein 51.8 28.9
228: Ernstbrunn/Cg641/1995 6 Sotkamo 2009 69.8 22.7
229: Berkel_L36943 10 Sotkamo 2009 44.6 21.2
230: Couvin/59Cg/97 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid protein 50.0 30.4
231: Pallasjarvi/63Cg/98 1 Puumala virus N and Ns genes, segment S, genomic RNA, Sotkamo2009 361 70.1
232: Munga/Mg16/05 5 Puumala virus N and Ns genes, segment S, genomic RNA, Sotkamo2009 68.0 27.4
233: Mignovillard/CgY02/2005 3 Puumala virus N and Ns genes, segment S, genomic RNA, Sotkamo2009 51.8 15.5
234: Perpignan1999 2 Sotkamo2009; Puumala virus genomic RNA for nucleocapsid protein 64.4 50.2
236: CH-14_Franche_Comté? Jura 3 Sotkamo2009 55.4 18.9
237: AR-21_Charleville_Mezières 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid protein 46.4 31.2
239: 167-4Charleville_Mezières 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid protein 51.8 31.2
240: 178-2Charleville_Mezières 2 Sotkamo 2009; Puumala virus genomic RNA for nucleocapsid 44.6 30.1
242: RU-11Ruminy-Troyes 3 Sotkamo 2009 60.8 23.3
Continued
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high (97.7% to 75%, resp.) and the BLASTN identified the Sotkamo strain without ambiguity. Down to 82.2% 
of sequence identity (seq230), the CR remained above 34%, still designing Sotkamo in priority by BLASTN, 
although some tiled sequences already hesitated in precise identification (seq232) or even failed in identification 
(seq226). Down to 82% of homology, the CR decreased dramatically and the tested sample failed to be identified 
in some cases. Plotting of the sequence identity to the CR confirmed these observations (Fig. 2): below 80.7% of 
identity between the tested and the tiled sequences the microarray becomes inefficient for specific detection; the 
window between 80.7% and 83.2% of identity is critical and versatile between no detection, detection with unspe-
cific determination, and precise genetic characterization of the tested sequence; higher than 83.2% of identity, the 
microarray identifies precisely the tiled sequence.
We verified that simultaneous detection was possible when plasmids containing the N protein coding region 
of the three hantavirus reference strains (PUUV Sotkamo 2009, TULV Moravia, HTNV 76/118) were mixed in 
pool (Supplement 3–4). The CR values of PUUV output sequences (seq222–seq243) were even higher (e.g. more 
determined nucleotides) for the pool of the three viruses, most likely due to cross-contribution from the three 
viruses in hybridizing the same sequence tiled on the chip, thus producing better results in BLASTN analysis 
(Supplements 3–4).
Tested virus 
(geographical origin)
Tiled sequence allowing detection 
(position on the chip)
BLASTN identification Score 
(total)
Call rate 
(%)nbr sequences
PUUV 335 Konnevesi 
(variant A) (Finland)
225: Sotkamo_NC_005224 1 Puumala virus strain PUUV/Konnevesi/Mg_O78A/2005 segment S 112 44.4
231: Pallasjarvi/63Cg/98 2 PUUV/Konnevesi/Mg_O78A/2005 127 38.6
234: Perpignan1999 48 PUUV/Konnevesi/Mg_O78A/2005 segment S 46.4 25.5
242: RU-11Ruminy-Troyes 5 Puumala virus strain PUUV/Konnevesi/Mg_O78A/2005 segment S 55.4 13.6
PUUV Slovenia 8098 
(Slovenia)
225: Sotkamo_NC_005224 37 Puumala virus isolate HtSi_339_p2012 nucleocapsid protein gene, partial 53.6 16.2
226: Kazan_Z84204 19 Puumala virus isolate HtSi_293_p2010 nucleocapsid protein gene, partial 44.6 12.7
228: Ernstbrunn/Cg641/1995 1 Puumala virus isolate HtSi_293_p2010 nucleocapsid protein gene, partial 167 55.9
231: Pallasjarvi/63Cg/98 36 Puumala virus isolate HtSi_339_p2012 nucleocapsid protein gene, partial 73.4 28.2
233: Mignovillard/CgY02/2005 41 Puumala virus isolate HtSi_293_p2010 nucleocapsid protein gene, partial 48.2 20.4
234: Perpignan1999 5 Puumala virus mRNA for nucleocapsid protein (N gene), strain Balkan-2 109 58.6
242: RU-11Ruminy-Troyes 7 Puumala virus isolate HtSi_293_p2010 nucleocapsid protein gene, partial 50.0 24.0
Table 3. Detection and genetic characterization of Puumala orthohantaviruses (PUUV) from various endemic 
area in Europe: PUUV isolates or laboratory strain were hybridized to the hantavirus sequences tiled on the 
PathogenID v3.0 resequencing microarray (seq222 to seq273; Table 1; Supplement 1). For each tested sample, 
the tiled sequences giving a significant signal are listed and the Call Rate (CR, i.e. % of correctly determined 
nucleotides) indicated. The corresponding raw sequences were subjected to BLASTN enquiry. The number 
(nbr) of BLASTN identical results is indicated; the most related sequence is indicated in italics and a maximum 
of the first 3 closer sequences are listed. “Total Score” evaluates the overall quality of the alignment by BLASTN. 
Complementary data including all sequences obtained following BLASTN analysis and further details are 
described in Supplement 5.
Tested virus  
(geographical origin)
Tiled sequence allowing detection 
(position on the chip)
BLASTN identification Score 
(total)
Call rate 
(%)nbr° sequences
DOBV-laboratory strain 245: Belgrade L41916 1 DOBV/Ano-Poroia/Afl9/1999 293 70.8
Saaremaa laboratory strain
245: Belgrade L41916 1 DOB/Saaremaa/160 V 137 44.1
247: Saaremaa virus AJ616854 1 DOB/Saaremaa/160 V 145 48.4
256: Hantavirus NC167 AB027523 9 DOB/Saaremaa/160 V 50.0 17.9
DOBV 15/01 (Slovenia)
245: DOBV Belgrade L41916 2 Dobrava-Belgrade virus isolate HtSi_275_p2008; HtSi_1036_a2001 688 97.5
247: Saaremaa virus AJ616854 12 HtSi_275_p2008; HtSi_1036_a2001 103 37.4
254: Hantaan Q32 AB027097 76 HtSi_275_p2008; HtSi_1036_a2001 69.8 24.2
262: Soochong SC1 AY675349 100 HtSi_275_p2008; HtSi_1036_a2001 51.8 24.4
DOBV 86/98 86/18 (Slovenia)
245: DOBV Belgrade L41916 8 Dobrava-Belgrade virus isolate HtSi_1012_a1997 159 43.1
246: DOBV Esl/81Aa/01 AY533120 5 Dobrava-Belgrade virus isolate HtSi_1012_a1997 221 61.8
247: Saaremaa virus AJ616854 9 Dobrava-Belgrade virus isolate HtSi_1012_a1997 99.0 39.6
Table 4. Detection and genetic characterization of Dobrava orthohantaviruses (DOBV) from various endemic 
area in Europe: DOBV isolates or laboratory strains were hybridized to the hantavirus sequences tiled on the 
PathogenID v3.0 resequencing microarray (seq222 to seq273; Table 1; Supplement 1). See legend of Table 3 for 
details on presented results.
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Mapping genetic diversity of hantaviruses circulating in Europe. The same technology validated 
with plasmids encoding hantavirus N protein was applied to tissue samples of PUUV, TULV, DOBV, SAAV, SEOV, 
TOPV infected rodents originating from different endemic areas in Europe as well as to supernatants of cells 
infected with laboratory strains (Tables 3–7; Supplement 5). Using RNA extracted from lung and liver of PUUV 
RNA positive bank voles captured in the Ardennes region of France in 201131 we first observed that, at compa-
rable viral RNA titer (Ct value), lung was more performing for hantavirus investigation on the chip (data not 
shown). Therefore, lung derived RNAs were priorized for further investigation.
Genetic characterization of Puumala viruses circulating in Europe. RNA extracts from supernatant of Vero E6 
cells infected with the PUUV Sotkamo strain, and RNA extracts from lungs of seven PUUV-infected bank voles 
originating from France, Germany, Finland or Slovenia were individually hybridized to the 22 PUUV sequences 
(seq222 to seq243) tiled on the PathogenID v3.0 resequencing microarray. It is of note that only two of the tested 
samples had their exact sequence tiled on the chip: the PUUV Sotkamo strain (seq225) and the French Ardennes 
PUUV strain 87 (seq237). When a significant signal was detected, the corresponding raw sequence was subjected 
to BLASTN enquiry for genetic typing (Table 3). Figure 3 pictures the results in the context of a phylogenetic tree 
illustrating the currently known diversity of PUUV by combining references sequences available in GenBank, 
sequences tiled on the chip (in red) and sequences of the tested viruses (in green). An unequivocal determination 
of the correct geographical variant was observed for all the tested samples at least with one tiled sequence (red dots 
in Fig. 3), even when the corresponding sequence was not tiled itself on the chip. In very few cases (<8%, orange 
dots in Fig. 3) tiled sequences designated only an approximate origin, however always in the same genetic cluster.
The French Ardennes PUUV lung-derived variants 87 and 153 were precisely identified by BLASTN not 
only using the very homologous French Ardennes PUUV tiled sequences (seq237-seq241), but also with tiled 
sequences from Belgium (seq222-seq223, seq230) or even from North-West Germany (seq229 for variant 153) 
more distant phylogenetically within the Central European (CE) clade. With the same logic, the three PUUV 
variants from Germany were precisely characterized by 91% (10/11; Gilserberg), 84% (5/6; Weissach) and 50% 
Figure 3. Phylogenetic analysis of European Puumala orthohantavirus (PUUV) genetically characterised by 
PathogenID v3.0 resequencing microarray. A phylogenetic tree backbone was first constructed from complete 
S segment coding sequences of reference hantaviruses available in GenBank using the maximum-likelihood 
method (ML) with PhyML v3.0, implemented in Seaview (v.4.6.1) with the most appropriate substitution 
model as determined by SMS program. Shorter sequences (tiled on the chip & tested viruses) were then 
placed in the backbone tree using RaxML. Nodes with branch support values > 0.8 are indicated by a red point 
(reference tree, aLRT branch support test) or by a blue point (phylogenetic placement of short sequence in 
the reference tree, rapid bootstrap procedure with MRE-based Bootstopping criterion). Scale bar represents 
the average number of substitutions per site. Under the tree are indicated the main geographical clusters of 
PUUV in Europe: CE (Central Europe); ALAD (Alpes-Adrian); S-SCA (South Scandinavia); FIN (Finland); 
RUS (Russia); LAT (Latvia); N-SCA (North Scandinavia); DEN (Denmark). The 22 PUUV sequences fixed 
on the chip (seq222 to seq243) are outlined in red, those of the 8 tested viruses in green. In the upper grid, the 
8 tested Puumala viruses (the laboratory PUUV Sotkamo strain and 7 European geographical variants) are 
presented with: their exact position in the tree (green diamond); the tiled sequences having permitted their 
detection (significant CR) with exact (red circles) or close (orange circles) genetic identification by BLASTN. 
Complementary information is described in Table 3 and Supplement 5.
1 0Scientific RepoRtS |         (2019) 9:12404  | https://doi.org/10.1038/s41598-019-47508-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
(3/6; Bramsche) of the hybridizing homologous and heterologous tiled sequences from the Central European 
clade (Table 3). More interestingly, the Konnevesi variant from Finland was exactly identified not only with tiled 
sequences from its specific clade (Finland, FIN) but also from the Central European (CE) clade. Equally, the vari-
ant 8098 from Slovenia (clade Alpes-Adrian, ALAD) was exactly identified with sequences from the ALAD clade, 
and also from the CE, FIN and Russia (RUS) clades. Finally, the laboratory PUUV Sotkamo strain was systemat-
ically identified by tiled sequences from almost all clades of the PUUV phylogenetic tree.
It is of note that these very precise characterisations could be obtained despite very low CR values, for example 
down to only 13% of defined nucleotides between the tested PUUV variant Slovenia 8098 and the tiled seq226 
(Kazan_Z84204) (Table 3). It is explained by the exact determination of short fragments (stretches) of significant 
sequence (e.g. minimum of 15 nucleotides) that allow precise BLASTN identification despite poor CR values 
(Table 3; Supplement 5).
From Puumala virus to other orthohantaviruses circulating in Europe. The potential in detection and genetic 
characterization of the resequencing chip Pathogen ID v3.0 was further evaluated for variants and laboratory 
strains of other hantavirus species circulating in Europe, namely DOBV, TULV, SEOV and TOPV. For this pur-
pose, 30 additional hantavirus sequences (seq244 to seq273) were tiled on the microarray.
For DOBV, RNA extracts from two cell supernatants infected with reference laboratory strains Belgrade and 
Saaremaa and RNA extracts from two Yellow-necked mice from Slovenia were tested (Table 4). All of them were 
exactly characterized: (1) by the DOBV (seq245-seq246) and/or SAAV (seq247) sequences tiled on the chip, as 
expected from the genetic similarity of both viruses; (2) more interestingly, by tiled sequences from more distant 
orthohantavirus species such as HTNV and Soochong virus. Significant results were also observed for TULV 
RNA extracts from one laboratory strain and three Common vole samples from Germany, Finland and Slovenia 
(Table 5). Following BLASTN, the correct sequence was either exclusively or at least dominantly characterized. 
Here again, precise detection and identification was possible with tiled sequences from very distant clades of 
vole-associated New world orthohantaviruses such as Prospect Hill or Sin Nombre orthohantaviruses (Table 5). 
Finally the SEOV present in RNA extracts from Norway rats from France and UK, although unknown when the 
chip was designed, was perfectly identified by heterologous SEOV tiled sequences (Table 6). Similarly for RNA 
extracts from a TOPV laboratory strain, in absence of the corresponding sequence tiled on the chip, the exact char-
acterization was achieved with PUUV tiled sequences (seq228, seq234, seq325) even at low CR of 15% (Table 7).
Discussion
Hantaviruses are zoonotic agents distributed world-wide. In Europe, rodent-borne hantaviruses are regularly 
provoking episodes of Hemorrhagic Fever with Renal Syndrome (HFRS). Tools to survey hantavirus circulation, 
geographical distribution and genetic features in the animal reservoir are essential to a better understanding and 
prevention of hantavirus infection in humans. Resequencing microarray has been shown powerful to precisely 
identify new genetic variants of emerging viruses15–21.
The present work represents a significant improvement of the resequencing microarray PathogenID devel-
oped through a collaborative study for detection and identification of orthohantaviruses circulating in Europe. 
The 1st and 2nd generations of PathogenID allowed to detect different viruses associated with hemorrhagic fevers, 
including hantaviruses; however they also showed their limits for the detection of PUUV20 which is the most 
common and widespread European hantavirus causing a mild form of HFRS, Nephropatia Emidemica (NE)2–8. 
Therefore, we have switched the strategy for the design of the 3rd generation PathogenID v3.0 used in this study. 
Tiled sequences did not target anymore the most conserved region of the genome, the L segment24, but the S 
Tested virus  
(geographical origin)
Tiled sequence allowing detection 
(position on the chip)
BLASTN identification Score 
(total)
Call rate 
(%)nbr° sequences
S666_13 Schlindermanderscheid 
(Germany)
261:ProspectHill M34011 2 S667_13_Marv; S666_13_Marv 64.4 25.9
264: Kosice144/Ma/95 2 S667_13_Marv; S666_13_Marv nucleocapsid protein gene, partial 46.4 23.2
265: Moravia5293Ma/94 2 S667_13_Marv; S666_13_Marv nucleocapsid protein gene, partial 107 38.1
TULV09_1000 Cunnersdorf 
(Germany) 265: Moravia5293Ma/94 9 09_1000_Marv nucleocapsid protein gene, partial cds 42.8 38.4
TULV laboratory strain Moravia
234: Perpignan1999 8 Tula virus S segment nucleocapsid protein mRNA, complete cds 55.4 23.8
244: CovictCreek107 49 Tula virus segment S, strain Tula/Moravia/5294 Ma/94, genomic RNA 42.8 16.2
261: Prospect Hill M34011 7 Tula/Moravia/5294 Ma/94, genomic RNA 48.2 30.9
263: Sennickerode_Sen05/204 72 Tula/Moravia/5294 Ma/94, genomic RNA 42.8 25.4
264: Kosice144/Ma/95 10 Tula/Moravia/5294 Ma/94, genomic RNA 55.4 21.2
265: Moravia5293Ma/94 1 Tula virus segment S, strain Tula/Moravia/5302 Ma/94 688 97.5
266: MG23/Omsk 8 Tula/Moravia/5302 Ma/94, genomic RNA 44.6 21.4
TULV (Slovenia) 265: Moravia5293Ma/94 1 Tula virus isolate HtSi_1087_a1999 nucleocapsid protein gene, partial cds 123 37.4
Table 5. Detection and genetic characterization of Tula orthohantaviruses (TULV) from various endemic 
area in Europe: TULV isolates or laboratory strain were hybridized to the hantavirus sequences tiled on the 
PathogenID v3.0 resequencing microarray (seq222 to seq273; Table 1; Supplement 1). See legend of Table 3 for 
details on presented results.
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segment encoding the N protein, which present two advantages: it is more efficient to discriminate variants within 
a species; more sequences are present in GenBank. After a critical analysis of the taxonomy, 52 representative 
hantavirus sequences were selected among those available at the time of the conception of the chip (Table 1). The 
resequencing methodology (Supplement 2) allowed to recognize both known viruses and previously unknown 
geographical variants.
Validation carried out by using hantavirus N protein encoding plasmids allowed to show a global tolerated 
divergence (up to 20%) between the tiled and the tested sequences for a correct identification of the PUUV pro-
totype strain Sotkamo (Table 1, Table 2, Fig. 1; Supplement 3). A synergic effect in detection was observed when 
three viral species (PUUV; TULV; HTNV) were simultaneously tested (Supplement 4), most likely due their 
cross-contribution in hybridizing orthohantavirus conserved nucleotides, favoring identification by BLASTN 
analysis.
Identification of European hantaviruses, PUUV, DOBV, TULV, SEOV, TOPV present in tissue samples or in 
supernatants of Vero E6 cells infected with laboratory strains was demonstrated not only using the homologous 
sequences tiled on the chip, but also using phylogenetically distant sequences (Tables 3–7; Fig. 3). The key factor 
for the precise characterization of the tested hantavirus sequence was obviously its genetic distance from the tiled 
one (Fig. 3) outlining the importance of designing the chip from sequences encompassing the global diversity of 
hantaviruses. However, even for samples with a low Call Rate (CR: % of determined/total number of nucleotides 
following hybridization), precise taxonomical identification was possible when short specific fragments of signif-
icant sequence (about 15 nucleotides) were obtained for BLASTN analysis (Supplement 5). This was in particular 
the case for TOPV and PUUV Konnevesi variant in the present study (Tables 3–7). A similar observation was 
previously reported for hemorrhagic fever viruses detected by PathogenID v.220. These short stretches of highly 
conserved sequences among hantavirus could serve for developing other hybridization methods such as hybrid 
captures43.
Geographical variants of PUUV, the most frequent hantavirus in Europe, was correctly determined in the 
different endemic areas, such as France, Germany, Finland, and Slovenia (Table 3, Fig. 3). SEOV isolate, recently 
pointed out to circulate both in France and in UK39–41, was also precisely characterized despite neither Lyon nor 
Cherwell isolates, respectively, were known when the microarray was designed (Table 6). Interestingly, both iso-
lates were detected and correctly identified from two heterologous sequences tiled on the microarray, SEOV and 
HTNV (Table 6). In any cases, when a tiled sequence did not achieve the determination of the exact geographical 
variant, it was at least designing the phylogenetic clade and the number of sequences tiled on the microarray 
always allowed to reach the deepest level of precision (Fig. 3).
Altogether, the results obtained with DOBV, TULV, SEOV and TOPV clearly outline the potential of Pathogen 
ID v3.0 to largely explore the hantavirus genetic space and to deliver precise identification of the species and local 
variants present in the infected tissue or in the cell supernatant. The suitability of this approach was demonstrated 
to map the wide diversity of hantaviruses within the European continent, including new variants unknown at the 
moment of the design of the chip. Detection by resequencing microarray which is applicable to both animal and 
human samples, is of interest for both research and public health aspects. Our results are promising to enlarge 
evaluation to other hantaviruses from different continents, both the pathogenic ones circulating in other endemic 
areas, such as Americas where they provoke severe HCPS and also in other animal reservoirs such as insectivores 
and bats.
Tested virus 
(geographical origin)
Tiled sequence allowing detection 
(position on the chip)
BLASTN identification\ Score 
(total)
Call rate 
(%)nbr° sequences
Seoul Lyon 892 
(France)
255: Hantavirus SEOV Z37 1 Seoul virus isolate LYON/Rn/FRA/2013/LYO852 segment S, complete 235 64.0
257: Hantavirus SEOV L99 28 Seoul virus isolate LYON/Rn/FRA/2013/LYO852 segment S, complete 127 44.6
258: SEOV 8039 10 Seoul virus isolate LYON/Rn/FRA/2013/LYO852 segment S, complete 140 53.6
Seoul Cherwell (UK)
255: Hantavirus SEOV Z37 1 Seoul virus nucleocapsid protein gene, complete cds Cherwell 161 52.9
257: Hantavirus SEOV L99 1 Seoul virus nucleocapsid protein gene, complete cds Cherwell 91.5 48.1
258: SEOV 8039 8 Seoul virus nucleocapsid protein gene, complete cds Cherwell 136 51.6
Table 6. Detection and genetic characterization of Seoul orthohantaviruses (SEOV) from various endemic 
area in Europe: SEOV isolates were hybridized to the hantavirus sequences tiled on the PathogenID v3.0 
resequencing microarray (seq222 to seq273; Table 1; Supplement 1). See legend of Table 3 for details on 
presented results.
Tested virus  
(geographical origin)
Tiled sequence allowing detection 
(position on the chip)
BLASTN identification Score 
(total)
Call rate 
(%)nbr° sequences
Topografov laboratory strain
228: Ernstbrunn/Cg641/1995 1 Topografov hantavirus S segment gene for N protein 44.6 15.0
234: Perpigna1999 12 Topografov hantavirus S segment gene for N protein 60.8 30.8
235: Fusong90006 1 Topografov hantavirus S segment gene for N protein 50.0 29.4
Table 7. Detection and genetic characterization of Topografov orthohantavirus (TOPV): the laboratory strain 
Topografov was hybridized to the hantavirus sequences tiled on the PathogenID v3.0 resequencing microarray 
(seq222 to seq273; Table 1; Supplement 1). See legend of Table 3 for details on presented results.
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